| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.082 | 0.09 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |